Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B

JOURNAL OF THROMBOSIS AND HAEMOSTASIS(2016)

Cited 0|Views20
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined